CP-464,005 inhaler

insulin inhalation formulation CP-464,005 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CP-464,005 inhaler, covering 2009-10-05 to 2009-10-05. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes [Phase 3]

See pricing